SOURCE: Healthnostics, Inc.

February 14, 2011 10:33 ET

Healthnostics Announces Joint Venture

NEW YORK, NY--(Marketwire - February 14, 2011) - Healthnostics, Inc., (PINKSHEETS: HNSS), announced a joint venture with U.S. News Marketing Co., a division of U.S. News Co., to tap a large niche need in the publicly-traded company market. U.S. News Marketing will service the marketing void common to the thousands of publicly-traded companies not employing in-house marketing personnel. The focus will be to assist those companies to disseminate news in a professional, effective, coherent, and timely manner for less than they currently pay for news distribution alone.

U.S. News Marketing selected the consulting division of Healthnostics for its expertise in the regulations, workings, and culture of publicly traded companies, and Healthnostics will receive 60 percent of gross revenues from the joint venture. This revenue is expected to significantly impact the Company's net profit.

U.S. News Marketing will offer professionalism, knowledge, and cost savings for its customers, but not advice or recommendations to the public.

About Healthnostics

Healthnostics, Inc. is a medical products manufacturer, system manufacturer, product distribution, and consulting company. Healthnostics' subsidiary, Worldwide Wipes Co., is a major manufacturer and distributor of medical and general swabs.

For further information please visit Healthnostics www.healthnostics.com, and Worldwide Wipes Co. www.wipesco.com.

And visit us on Facebook at www.facebook.com/Healthnostics.

This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.

Contact Information

  • Contact:
    Healthnostics, Inc.
    Investor Relations
    P. 301-956-3342
    Email Contact